EC 231-130-8
chemXplore tracks 5 projects producing silicone, of which one is active.
Of the active ones, 1 expansion.
Suite of cell-level materials targeting high-energy-density and emerging chemistries, bundling binders, dispersants, rheology modifiers and specialty additives to aid performance and manufacturability.
Q2 sales €1.52bn; EBITDA €211m aided by cost cuts and a €36.7m pension revaluation; net income includes €243m from Siltronic sale; full‑year guidance adjusted.
Operating EPS $1.44 and GAAP EPS $0.99; cash from operations $1.3B; self‑help benefits raised by ~$200M to >$1.3B; polyethylene-led price gains offset by lower volumes and maintenance.
EBITDA fell on weak silicon prices; raised NOK 1.8bn, refinanced EUR 1bn facility and obtained NOK 750m NIB loan; Elkem Iceland reclassified as discontinued.
Leadership change effective 3 August 2026; incoming CEO returns with industrial and investment experience and prior Elkem roles; outgoing CEO moves to board chair after 17 years.
Coating raises silicone wettability >20×, cuts friction ~90%, forms ~20 nm durable layer by heat-induced polymer self-assembly for lenses and catheters.
EBITDA fell 24% YoY. Silicones sale to Bluestar boosts focus and flexibility. Safety incident in Lyon. Market uncertainties persist, but strong cost positions aid adaptation.
Elkem to transfer Silicones division to Bluestar, settling through share redemption. Transaction awaits shareholder and regulatory approvals, expected to close by May 2026.
Prices for silicone products rise due to increased platinum costs, affecting sectors like automotive and medical. Existing contracts will be amended.
A second employee has died from the Saint-Fons accident. Two remain hospitalized. Operations are temporarily shut down. Internal and external investigations are underway.
plants
The 3 with the most plants, of 4 producers.
A subscription lists every plant we track for silicone, with its owners and capacity. What a subscription does →
